Omeros OMER
NASDAQ OMER
$18.95 -0.16 (-0.84%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omeros (OMER) Capital Expenditures (2010 - 2026)

Omeros (OMER) posted Capital Expenditures of $11000.0 for Q3 2025, down 15.38% sequentially from $13000.0 in Q2 2025, and up 1000.0% YoY from $1000.0 in Q3 2024.

Analysis

Omeros (OMER) Capital Expenditures (2010 - 2026) Analysis & Trends

Omeros has reported Capital Expenditures for 16 years, with the latest figure at $11000.0 in Q3 2025.

  • Quarterly Capital Expenditures rose 1000.0% year-over-year to $11000.0 in Q3 2025, while the trailing twelve-month figure through Mar 2026 was $24000.0 (down 83.78% YoY) and the FY2025 annual result came in at $65000.0, down 60.61% from the prior year.
  • Capital Expenditures declined to $11000.0 in Q3 2025 per OMER's latest filing, from $13000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $275000.0 in Q2 2023 and troughed at -$3000.0 in Q3 2022.
  • A 5-year average of $58937.5 and a median of $37000.0 in 2023 frame the typical range for Capital Expenditures.
  • The sharpest annual moves came in 2022 and 2023: Capital Expenditures plunged 102.91% in 2022, then surged 1200.0% in 2023.
  • Over 5 years, Capital Expenditures stood at $74000.0 in 2021, then plunged by 82.43% to $13000.0 in 2022, then soared by 807.69% to $118000.0 in 2023, then plunged by 77.97% to $26000.0 in 2024, then tumbled by 57.69% to $11000.0 in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods registered $11000.0, $13000.0, and $41000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 37.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.29 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 25.02 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 34.68 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 251.02 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.26 Mn
10 Omeros 1.38 Bn 1.38 Bn 27.73 Mn 45,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 45,000.00
Sep 30, 2025 11,000.00
Jun 30, 2025 13,000.00
Mar 31, 2025 41,000.00
Dec 31, 2024 26,000.00
Sep 30, 2024 1,000.00
Jun 30, 2024 80,000.00
Mar 31, 2024 58,000.00
Dec 31, 2023 118,000.00
Sep 30, 2023 33,000.00
Jun 30, 2023 275,000.00
Dec 31, 2022 13,000.00
Sep 30, 2022 -3,000.00
Dec 31, 2021 74,000.00
Sep 30, 2021 103,000.00
Jun 30, 2021 88,000.00
Mar 31, 2021 12,000.00
Sep 30, 2020 73,000.00
Jun 30, 2020 144,000.00
Mar 31, 2020 66,000.00